Companies → WELL Health Technologies Corp
Save to list
Remove

WELL Health Technologies Corp

Canada, British Columbia, Vancouver
Description
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare. The company also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, it operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); Apps.health, a digital health app marketplace; billing and revenue cycle management solutions for billing and back-office services comprising billing-as-a-service outsourcing services to doctors; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, an EMR platform. The company was founded in 2010 and is headquartered in Vancouver, Canada.
Address:

375 Water St Suite 550 Vancouver

BC

V6B 5C6 Canada

Website:
Revenue
Recent news:

WELL Health Record Revenue Spurs Clinic Growth And Wellstar Spin Out

WELL Health Technologies (TSX:WELL) reported record annual revenue and a 52% increase in yearly revenue. The company expanded its clinic footprint and patient visits over the year. WELL Health advanced growth plans through new medical billing acquisitions. The company is preparing to spin out its Wellstar business as a separate entity. WELL Health Technologies, a digital health and clinic operator, operates at the intersection of primary care, virtual care, and health IT services. With more...

Source: Simply Wall St. Mar 21, 2026

WELL Health Technologies Corp (WHTCF) Q4 2025 Earnings Call Highlights: Record Revenue and ...

WELL Health Technologies Corp (WHTCF) reports a 52% revenue increase and strategic expansions, despite facing cyber incidents and compliance challenges.

Source: GuruFocus.com Mar 19, 2026

WELL Health Technologies Q4 Earnings Call Highlights

WELL Health Technologies (TSE:WELL) used its fiscal fourth-quarter and full-year 2025 earnings call to highlight a step-change in reported profitability, continued expansion of its Canadian clinic footprint, and progress on strategic initiatives tied to its technology platforms and U.S. portfolio re

Source: MarketBeat Mar 19, 2026

WELL Health Subsidiary Wellstar Acquires Two Medical Billing Assets in Ontario and Quebec

WELL Health Technologies (WELL.TO) said Tuesday that its subsidiary Wellstar has completed the $4.8

Source: MT Newswires Mar 17, 2026

Is WELL Health (TSX:WELL) Quietly Redefining Its Moat With The New WELLTRUST AI Platform?

In February 2026, WELL Health Technologies and HEALWELL AI launched the first phase of the WELLTRUST platform across WELL-operated Canadian clinics, creating a secure, consent-driven system to match patients to clinical research while maintaining privacy and regulatory compliance. The rollout of WELLTRUST, powered by HEALWELL’s AI for clinical trial recruitment, builds directly on WELL Health’s growing network of 252 clinics and 4.3 million annual patient visits, potentially deepening the...

Source: Simply Wall St. Feb 27, 2026

Stifel Canada on WELL Health Canadian Patient Metrics

WELL Health Technologies (WELL.TO) this week highlighted patient metrics for its Canadian clinic net

Source: MT Newswires Feb 25, 2026

TSXV - Delayed Quote - CAD
WELL.TO
3.77 -0.42 (-10.02%)
At close March 20 20:00 UTC
Candle
Line
1M
6M
1Y
5Y
Financial Statistics
Valuation Measures
Current
Quarterly
As of 03/21/2026
Market Cap: 957.14 M
Enterprise Value: 1.45 B
Trailing P/E: 31.46
Forward P/E: 9.67
PEG Ratio (5yr expected): N/A
Price/Sales (ttm): 0.76
Price/Book (mrq): 1.13
Enterprise Value/Revenue: 1.16
Enterprise Value/EBITDA: 12.27
Financial Highlights
Profitability and Income Statement
Profit Margin: -1.78%
Return on Assets (ttm): 1.93%
Return on Equity (ttm): -3.07%
Revenue (ttm): 1.25 B
Net Income Avi to Common (ttm): -22.21 M
Diluted EPS (ttm): -0.09
Balance Sheet and Cash Flow
Total Cash (mrq): 82.55 M
Total Debt/Equity (mrq): 63.37%
Levered Free Cash Flow (ttm): 113.52 M
Company is likely to buy
Company is likely to sell
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.